This is an investigational study. Blinatumomab is FDA approved and commercially available for the treatment of other types of ALL. Ponatinib is FDA approved and commercially available for the treatment of several types of leukemia, including some types of Ph+ ALL. It is investigational to use the study drugs in combination with each other.